Our technology is being used in different clinical trials, demonstrating their potential to gather data on a range of factors such as lifestyle, environmental exposures, medication use, and patient-reported outcomes. This comprehensive approach allows researchers to analyze data in a more nuanced way, leading to more precise and effective treatments for patients.
Nia
Sorea
milderma
Urticaria App Chronic Rhinosinusitis App Sunburn App
Berlin, 15.5.2023 – Nia Health, ein Spin-off der Berliner Universitätsmedizin Charité, bietet digitale Lösungen für die Behandlung und Unterstützung von Betroffenen mit chronischen Hauterkrankungen. Zu
Berlin, 15.5.2023 – Nia Health, a spin-off of Charité Universitätsmedizin Berlin, offers digital solutions for the treatment and support of sufferers of chronic skin conditions.
Berlin, 02/16/2023. Nia Health GmbH, manufacturer of the atopic dermatitis app Nia, and the healthcare company Sanofi will continue and further expand their successful collaboration
Berlin/Neu-Isenburg, December 19, 2022. Berlin-based Nia Health GmbH and Neu-Isenburg-based pharmaceutical company LEO Pharma have agreed to expand their cooperation. Together, the digital therapy management
Berlin/Hamburg, den 19.10.2022: Das Berliner Digital Health-Unternehmen Nia HealthGmbH und der Deutsche Psoriasis (Schuppenflechte) ist eine chronisch-entzündliche Erkrankung, die durch schuppende und juckende Hautausschläge gekennzeichnet
Berlin, 17 June 2022. Nia Health receives the DEEP TECH Award in the Artificial Intelligence category. Among 70 participating companies, the digital medical device manufacturer
Are you interested in an innovative, medical solution based on our proven tech infrastructure? Let’s build something great together!
